These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14981663)

  • 1. Recently synthesized class of vinylphosphonates as potent matrix metalloproteinase (MMP-2) inhibitors.
    Al-Quntar AA; Baum O; Reich R; Srebnik M
    Arch Pharm (Weinheim); 2004 Feb; 337(2):76-80. PubMed ID: 14981663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.
    Breuer E; Salomon CJ; Katz Y; Chen W; Lu S; Röschenthaler GV; Hadar R; Reich R
    J Med Chem; 2004 May; 47(11):2826-32. PubMed ID: 15139760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
    Li Q; Fang H; Xu W
    Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
    Nuti E; Orlandini E; Nencetti S; Rossello A; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2007 Mar; 15(6):2298-311. PubMed ID: 17276072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors.
    Tsukada T; Takahashi M; Takemoto T; Kanno O; Yamane T; Kawamura S; Nishi T
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5909-12. PubMed ID: 19762234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metallo-proteinase (MMP-2) organoboronate inhibitors.
    Ali HA; Berkovitz R; Reich R; Srebnik M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):183-7. PubMed ID: 15065076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors.
    Bhattacharya AK; Rana KC
    Bioorg Med Chem; 2011 Dec; 19(23):7129-35. PubMed ID: 22019466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
    Agamennone M; Campestre C; Preziuso S; Consalvi V; Crucianelli M; Mazza F; Politi V; Ragno R; Tortorella P; Gallina C
    Eur J Med Chem; 2005 Mar; 40(3):271-9. PubMed ID: 15725496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamoylphosphonate matrix metalloproteinase inhibitors 3: in vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis.
    Reich R; Katz Y; Hadar R; Breuer E
    Clin Cancer Res; 2005 May; 11(10):3925-9. PubMed ID: 15897594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, SAR, and biological evaluation of alpha-sulfonylphosphonic acids as selective matrix metalloproteinase inhibitors.
    Rubino MT; Agamennone M; Campestre C; Fracchiolla G; Laghezza A; Loiodice F; Nuti E; Rossello A; Tortorella P
    ChemMedChem; 2009 Mar; 4(3):352-62. PubMed ID: 19204958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.
    Rossello A; Nuti E; Carelli P; Orlandini E; Macchia M; Nencetti S; Zandomeneghi M; Balzano F; Uccello Barretta G; Albini A; Benelli R; Cercignani G; Murphy G; Balsamo A
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1321-6. PubMed ID: 15713379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.
    Rossello A; Nuti E; Catalani MP; Carelli P; Orlandini E; Rapposelli S; Tuccinardi T; Atkinson SJ; Murphy G; Balsamo A
    Bioorg Med Chem Lett; 2005 May; 15(9):2311-4. PubMed ID: 15837315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2).
    Rossello A; Nuti E; Orlandini E; Carelli P; Rapposelli S; Macchia M; Minutolo F; Carbonaro L; Albini A; Benelli R; Cercignani G; Murphy G; Balsamo A
    Bioorg Med Chem; 2004 May; 12(9):2441-50. PubMed ID: 15080939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel three-component route to diastereoselective synthesis of trisubstituted vinylphosphonates using phosphites, acetylenic esters, and aroyl chlorides.
    Rostamnia S; Alizadeh A; Zhu LG
    J Comb Chem; 2009; 11(1):143-5. PubMed ID: 19099427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).
    Zhang YM; Fan X; Yang SM; Scannevin RH; Burke SL; Rhodes KJ; Jackson PF
    Bioorg Med Chem Lett; 2008 Jan; 18(1):405-8. PubMed ID: 17980583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of phenylalanine ammonia-lyase: substituted derivatives of 2-aminoindane-2-phosphonic acid and 1-aminobenzylphosphonic acid.
    Miziak P; Zoń J; Amrhein N; Gancarz R
    Phytochemistry; 2007 Feb; 68(4):407-15. PubMed ID: 17215011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.